Medicinal Evolution of Natural Hormones to Transform Drug Treatment of Obesity

NIH Director’s Lecture | Wednesday, November 18, 2026 | 2:00 to 3:00 p.m. ET

Dr. Richard DiMarchi is Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University. A member of the National Academy of Medicine and National Inventors Hall of Fame, he previously held leadership roles at Eli Lilly and Novo Nordisk. He contributed to the discovery and development of Humalog®, Glucagon®, and Forteo® and pioneered multimode agonists for diabetes and obesity. Dr. DiMarchi holds more than 100 U.S. patents, has authored over 250 scientific publications, and co-founded six biotechnology companies. In 2026, he was named a recipient of the Broermann Medical Innovation Award for groundbreaking contributions to metabolic research.

View the Videocast